Labcorp Holdings Inc (LH) shares projected to rise by 25.43%

Kevin Freeman

Labcorp Holdings Inc [LH] stock is trading at $250.69, down -0.65%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The LH shares have gain 1.03% over the last week, with a monthly amount drifted -10.35%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Labcorp Holdings Inc [NYSE: LH] stock has seen the most recent analyst activity on July 10, 2025, when HSBC Securities downgraded its rating to a Hold but kept the price target unchanged to $260 for it. Previously, Redburn Atlantic started tracking the stock with Buy rating on April 02, 2025, and set its price target to $276. On March 04, 2025, upgrade upgraded it’s rating to Buy and revised its price target to $300 on the stock. Evercore ISI upgraded its rating to a Outperform and increased its price target to $265 on January 07, 2025. HSBC Securities upgraded its rating to Buy for this stock on October 30, 2024. In a note dated October 01, 2024, Piper Sandler initiated a Neutral rating and provided a target price of $235 on this stock.

Labcorp Holdings Inc [LH] stock has fluctuated between $209.38 and $293.72 over the past year. Currently, Wall Street analysts expect the stock to reach $314.43 within the next 12 months. Labcorp Holdings Inc [NYSE: LH] shares were valued at $250.69 at the most recent close of the market. An investor can expect a potential return of 25.43% based on the average LH price forecast.

Analyzing the LH fundamentals

Labcorp Holdings Inc [NYSE:LH] reported sales of 13.77B for the trailing twelve months, which represents a growth of 8.58%. Gross Profit Margin for this corporation currently stands at 0.28% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.1 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.75.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 247.65 points at the first support level, and at 244.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 253.37, and for the 2nd resistance point, it is at 256.05.

Ratios To Look Out For

For context, Labcorp Holdings Inc’s Current Ratio is 1.55. As well, the Quick Ratio is 1.35, while the Cash Ratio is 0.23. Considering the valuation of this stock, the price to sales ratio is 1.51, the price to book ratio is 2.39 and price to earnings (TTM) ratio is 24.62.

Transactions by insiders

Recent insider trading involved Parham Richelle P, Director, that happened on Oct 31 ’25 when 7009.0 shares were sold. Director, Parham Richelle P completed a deal on Oct 31 ’25 to buy 7009.0 shares. Meanwhile, EVP, Chief Legal Officer van der Vaart Sandra D sold 3903.0 shares on Aug 13 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.